Oral drugs for the treatment of Multiple Sclerosis

Publisher： Govi-Verlag

ISSN： 2195-2175

Source： PHARMAKON, Vol.2, Iss.6, 2014-11, pp. : 396-402

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs Treatment of Pain in Multiple Sclerosis

By  

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. : 227-233

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging oral drugs for relapsing–remitting multiple sclerosis

By Gasperini Claudio   Ruggieri Serena  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 697-712

Informa Healthcare

Access to resources Recommend Favorite

From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis

By  

Current Neuropharmacology, Vol. 15, Iss. 6, 2017-07 ,pp. : 874-891

Bentham Science Publishers

Access to resources Recommend Favorite

Sustained release oral fampridine in the treatment of multiple sclerosis

By Kachuck Norman J  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 12, 2009-08 ,pp. : 2025-2035

Informa Healthcare

Access to resources Recommend Favorite

Teriflunomide: a novel oral treatment for relapsing multiple sclerosis

By Sartori Arianna   Carle Dawn   Freedman Mark S  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 1019-1027

Informa Healthcare

Access to resources Recommend Favorite